Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: A project of the Kyushu University Liver Disease Study Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

225

HTML

1652

Figures (1-2)

142

Tables (1-1)

138

Sum=2157

Feb 7, 2006 (publication date) through Apr 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 7, 2006; 12(5): 784-790
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.784

Full Size Figure Download Figure

Figure 2 Relationship between the sustained virological response rates and the length of ribavirin treatment period of the 173 studied patients.

Citation: Furusyo N, Katoh M, Tanabe Y, Kajiwara E, Maruyama T, Shimono J, Sakai H, Nakamuta M, Nomura H, Masumoto A, Shimoda S, Takahashi K, Azuma K, Hayashi J, Group KULDS. Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: A project of the Kyushu University Liver Disease Study Group. World J Gastroenterol 2006; 12(5): 784-790
URL: https://www.wjgnet.com/1007-9327/full/v12/i5/784.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i5.784